{"id":"https://openalex.org/W2099863297","doi":"https://doi.org/10.1002/jps.2600740711","title":"Pharmacologically Active Conformation of Disopyramide: Evidence from Apparent pKa Measurements","display_name":"Pharmacologically Active Conformation of Disopyramide: Evidence from Apparent pKa Measurements","publication_year":1985,"publication_date":"1985-07-01","ids":{"openalex":"https://openalex.org/W2099863297","doi":"https://doi.org/10.1002/jps.2600740711","mag":"2099863297","pmid":"https://pubmed.ncbi.nlm.nih.gov/4032248"},"language":"en","primary_location":{"id":"doi:10.1002/jps.2600740711","doi":"https://doi.org/10.1002/jps.2600740711","is_oa":false,"landing_page_url":"https://doi.org/10.1002/jps.2600740711","pdf_url":null,"source":{"id":"https://openalex.org/S130661733","display_name":"Journal of Pharmaceutical Sciences","issn_l":"0022-3549","issn":["0022-3549","1520-6017"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmaceutical Sciences","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5074455557","display_name":"Jeffrey L. Czeisler","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Jeffrey L. Czeisler","raw_affiliation_strings":["Pharmaceutical Development Department, Research and Development Division, G. D. Searle and Company, Skokie, IL 60077"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Development Department, Research and Development Division, G. D. Searle and Company, Skokie, IL 60077","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5074036101","display_name":"Ragab El\u2010Rashidy","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ragab M. El-Rashidy","raw_affiliation_strings":["Pharmaceutical Development Department, Research and Development Division, G. D. Searle and Company, Skokie, IL 60077"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Development Department, Research and Development Division, G. D. Searle and Company, Skokie, IL 60077","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5074455557"],"corresponding_institution_ids":[],"apc_list":{"value":3620,"currency":"USD","value_usd":3620},"apc_paid":null,"fwci":0.7163,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":{"value":0.69940909,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"74","issue":"7","first_page":"750","last_page":"754"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10217","display_name":"Cardiac electrophysiology and arrhythmias","score":0.7235999703407288,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10217","display_name":"Cardiac electrophysiology and arrhythmias","score":0.7235999703407288,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12191","display_name":"Physical Organic Chemistry and Reaction Kinetics","score":0.038600001484155655,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.0364999994635582,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/disopyramide","display_name":"disopyramide","score":1.0},{"id":"https://openalex.org/keywords/intramolecular-hydrogen-bonding","display_name":"intramolecular hydrogen bonding","score":0.9120000004768372},{"id":"https://openalex.org/keywords/apparent-pka","display_name":"apparent pKa","score":0.8939999938011169},{"id":"https://openalex.org/keywords/amido-group","display_name":"amido group","score":0.5519999861717224},{"id":"https://openalex.org/keywords/pyridine-ring-conformation","display_name":"pyridine ring conformation","score":0.8989999890327454},{"id":"https://openalex.org/keywords/antiarrhythmic-activity","display_name":"antiarrhythmic activity","score":0.968999981880188},{"id":"https://openalex.org/keywords/anticholinergic-activity","display_name":"anticholinergic activity","score":0.9980000257492065},{"id":"https://openalex.org/keywords/pheniramine","display_name":"pheniramine","score":0.9229999780654907},{"id":"https://openalex.org/keywords/conformational-restriction","display_name":"conformational restriction","score":0.640999972820282},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.6110000014305115}],"concepts":[{"id":"https://openalex.org/C2779831137","wikidata":"https://www.wikidata.org/wiki/Q425120","display_name":"Disopyramide","level":2,"score":0.8928787708282471},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.7972261905670166},{"id":"https://openalex.org/C75079739","wikidata":"https://www.wikidata.org/wiki/Q1571801","display_name":"Intramolecular force","level":2,"score":0.7397071123123169},{"id":"https://openalex.org/C2779485729","wikidata":"https://www.wikidata.org/wiki/Q210385","display_name":"Pyridine","level":2,"score":0.6881377696990967},{"id":"https://openalex.org/C112887158","wikidata":"https://www.wikidata.org/wiki/Q169324","display_name":"Hydrogen bond","level":3,"score":0.6675543785095215},{"id":"https://openalex.org/C2780378348","wikidata":"https://www.wikidata.org/wiki/Q25351438","display_name":"Ring (chemistry)","level":2,"score":0.6213806867599487},{"id":"https://openalex.org/C2778689640","wikidata":"https://www.wikidata.org/wiki/Q113259","display_name":"Anticholinergic","level":2,"score":0.5759618878364563},{"id":"https://openalex.org/C32909587","wikidata":"https://www.wikidata.org/wiki/Q11369","display_name":"Molecule","level":2,"score":0.5383037328720093},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.4768301546573639},{"id":"https://openalex.org/C147597530","wikidata":"https://www.wikidata.org/wiki/Q369472","display_name":"Computational chemistry","level":1,"score":0.3410351574420929},{"id":"https://openalex.org/C155647269","wikidata":"https://www.wikidata.org/wiki/Q243455","display_name":"Medicinal chemistry","level":1,"score":0.31263595819473267},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.14106076955795288},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.13691043853759766},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.07474681735038757},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.06862965226173401}],"mesh":[{"descriptor_ui":"D000889","descriptor_name":"Anti-Arrhythmia Agents","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002627","descriptor_name":"Chemistry, Physical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004206","descriptor_name":"Disopyramide","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D004206","descriptor_name":"Disopyramide","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D006863","descriptor_name":"Hydrogen-Ion Concentration","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008968","descriptor_name":"Molecular Conformation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010632","descriptor_name":"Pheniramine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D055598","descriptor_name":"Chemical Phenomena","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1002/jps.2600740711","doi":"https://doi.org/10.1002/jps.2600740711","is_oa":false,"landing_page_url":"https://doi.org/10.1002/jps.2600740711","pdf_url":null,"source":{"id":"https://openalex.org/S130661733","display_name":"Journal of Pharmaceutical Sciences","issn_l":"0022-3549","issn":["0022-3549","1520-6017"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmaceutical Sciences","raw_type":"journal-article"},{"id":"pmid:4032248","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/4032248","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of pharmaceutical sciences","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.5683000087738037,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":21,"referenced_works":["https://openalex.org/W620132579","https://openalex.org/W1497732534","https://openalex.org/W1537867938","https://openalex.org/W1560694348","https://openalex.org/W1576893770","https://openalex.org/W1972050547","https://openalex.org/W2022037333","https://openalex.org/W2037281743","https://openalex.org/W2041887632","https://openalex.org/W2055551164","https://openalex.org/W2058855577","https://openalex.org/W2071716489","https://openalex.org/W2076601862","https://openalex.org/W2091544189","https://openalex.org/W2093205054","https://openalex.org/W2166199762","https://openalex.org/W2321464198","https://openalex.org/W2330902547","https://openalex.org/W2333005271","https://openalex.org/W2417963427","https://openalex.org/W4245126555"],"related_works":["https://openalex.org/W3143032379","https://openalex.org/W2951611713","https://openalex.org/W2084381833","https://openalex.org/W2011607691","https://openalex.org/W2071294840","https://openalex.org/W2314891209","https://openalex.org/W1998151458","https://openalex.org/W7096081289","https://openalex.org/W2054850812","https://openalex.org/W2953083146"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}